Viimane versioon :
08/05/2024
Parasiidivastane ravim   Metronidazole  
Suukaudne lahus
Süsteravim
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid Stabiilsust mõjutavad faktorid Sobimatus Viited Pdf
   Keemiline struktuur  

Suukaudne lahus
Viited   Suukaudne lahus   Viited : Metronidazole  
Tüüp Avaldamine
2441 Ajaleht Allen LV, Jr, Erickson MA,
Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids
Am J Health-Syst Pharm 1996 ; 53: 2073-2078.
2663 Ajaleht Alexander KS, Vangala SSKS, Dollimore D.
The formulation development and stability of metronidazole suspension.
Int J Pharm Compound 1997 ; 1: 200-205.
2695 Ajaleht Donnelly Ronald F, Ying James.
Stability of Metronidazole Suspensions.
Int J Pharm Compound 2015 ; 19, 3: 248-251.
2702 Ajaleht Mathew M, Gupta VD, Bethea C.
Stability of metronidazole benzoate in suspensions
J Clin Pharm Ther 1994 ; 19, 1: 31-34.
4375 Ajaleht Jarouche M, Ibrahim M, Pearson J, Venkataya B, Low M, Rowe J.
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets.
Int J Pharm Compound 2020 ;24,1:77-82
4575 Ajaleht Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Richard A.
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.
Int J Pharm Compound 2021 ;25,2:169-175

  Mentions Légales